We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BSEM market cap is 81.78M. The company's latest EPS is USD -0.9180 and P/E is -9.64.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.63M | 2.52M | 4.34M | 6.88M | 16.69M |
| Operating Income | -5.68M | -1.84M | -1.43M | -4.68M | -7.78M |
| Net Income | -6.34M | -2.39M | -1.37M | -7.08M | -8.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.15M | 2.67M | 2.74M | 3.47M | 14.56M |
| Total Liabilities | 7.09M | 8.3M | 8.14M | 7.42M | 15.9M |
| Total Equity | -3.94M | -5.63M | -5.4M | -3.95M | -1.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -845k | -582k | -625k | -1.64M | -3.5M |
| Investing | 45k | N/A | 61k | -470k | -210k |
| Financing | -235k | 542k | 804k | 573k | 3.18M |
| Market Cap | 81.78M |
| Price to Earnings Ratio | -9.64 |
| Price to Sales Ratio | 4.9 |
| Price to Cash Ratio | 341.7 |
| Price to Book Ratio | -60.85 |
| Dividend Yield | - |
| Shares Outstanding | 9.24M |
| Average Volume (1 week) | 19.61k |
| Average Volume (1 Month) | 20.1k |
| 52 Week Change | 449.69% |
| 52 Week High | 15.50 |
| 52 Week Low | 1.21 |
| Spread (Intraday) | 0.46 (4.95%) |
| Company Name | BioStem Technologies Inc (PK) |
| Address |
2836 center prt circle pompano beach, florida 33604 |
| Website | https://www.biostemtech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
